Fate and disposition of bromocriptine in animals and man. I: Structure elucidation of the metabolites
- 1 October 1982
- journal article
- research article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 7 (4) , 281-292
- https://doi.org/10.1007/bf03189631
Abstract
A total of 16 metabolites of bromocriptine could be isolated from rat bile and incubates of rat liver cell preparations using [6-methyl-14C]bromocriptine as substrate. Separation and purification was achieved by reversed-phase liquid chromatography and preparative thin-layer chromatography in conjunction with radioactivity monitoring. Structure elucidation was based on spectroscopic data (UV, IR, NMR, EI- and FD-MS) and the results of amino acid analysis after acid hydrolysis. Based on the identified metabolites four principal transformation processes could be described : — Hydrolytic cleavage of the amide bridge leading to the formation of 2-bromolysergic acid amide (3) and 2-bromolysergic acid (7). — epimerization at position 8 of the bromolysergic acid moiety to the iso-derivatives (isobromocriptine, 2-bromo-isolysergic acid (6), its amide (1), etc.) — regiospecific oxidation at position 8′ in the proline fragment generating stereoisomeric 8′-hydroxy-bromocriptines (21–24) — further oxidation of the 8′-hydroxylated derivatives by either the introduction of a second hydroxy group at position 9′ to give dihydroxylated derivatives (detected as conjugates with glucuronic acid: metabolites29, 30 and31), or the opening of the proline ring under formation of the metabolites4 and5 containing glutamic acid instead of proline (7′, 8′-seco-8′-carboxy-bromocriptines). — Hydrolytic cleavage of the amide bridge leading to the formation of 2-bromolysergic acid amide (3) and 2-bromolysergic acid (7). — epimerization at position 8 of the bromolysergic acid moiety to the iso-derivatives (isobromocriptine, 2-bromo-isolysergic acid (6), its amide (1), etc.) — regiospecific oxidation at position 8′ in the proline fragment generating stereoisomeric 8′-hydroxy-bromocriptines (21–24) — further oxidation of the 8′-hydroxylated derivatives by either the introduction of a second hydroxy group at position 9′ to give dihydroxylated derivatives (detected as conjugates with glucuronic acid: metabolites29, 30 and31), or the opening of the proline ring under formation of the metabolites4 and5 containing glutamic acid instead of proline (7′, 8′-seco-8′-carboxy-bromocriptines). It is suggested that the primary and principal metabolic attack occurs at the proline fragment of the drug. In contrast to the biotransformation of ergoline compounds, none of the bromocriptine metabolites detected showed oxidative transformations in the lysergic acid half of the molecule.This publication has 5 references indexed in Scilit:
- Trapping of metabolically generated electrophilic species with cyanide ion: metabolism of 1-benzylpyrrolidineJournal of Medicinal Chemistry, 1980
- DISTRIBUTION AND EXCRETION IN THE RAT AND MONKEY OF [BR-82] BROMOCRIPTINE1979
- Biopharmaceutical AspectsPublished by Springer Nature ,1978
- HUMAN PLASMA LEVELS OF SOME ANTI‐MIGRAINE DRUGSHeadache: The Journal of Head and Face Pain, 1976
- Chapter 4 Preparation of Isolated Rat Liver CellsPublished by Elsevier ,1976